BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi B, Lee H, Min J, Choe H, Choi Y, Son Y, Ahn H, Suh Y, Goldenring JR, Yang H. Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer. CBM 2017;19:231-9. [DOI: 10.3233/cbm-160147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021;9:1448. [PMID: 34680565 DOI: 10.3390/biomedicines9101448] [Reference Citation Analysis]
2 Lee JWJ, Zhu F, Srivastava S, Tsao SK, Khor C, Ho KY, Fock KM, Lim WC, Ang TL, Chow WC, So JBY, Koh CJ, Chua SJ, Wong ASY, Rao J, Lim LG, Ling KL, Chia CK, Ooi CJ, Rajnakova A, Yap WM, Salto-Tellez M, Ho B, Soong R, Chia KS, Teo YY, Teh M, Yeoh KG. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut 2022;71:854-63. [PMID: 33975867 DOI: 10.1136/gutjnl-2021-324057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
3 Carino A, Graziosi L, Marchianò S, Biagioli M, Marino E, Sepe V, Zampella A, Distrutti E, Donini A, Fiorucci S. Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential. Front Oncol 2021;11:663771. [PMID: 34012923 DOI: 10.3389/fonc.2021.663771] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Xin Y, Shang X, Sun X, Liu Y, Xu G, Xue G. Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:2130229. [PMID: 34567204 DOI: 10.1155/2021/2130229] [Reference Citation Analysis]